Relaxed eligibility criteria would double patient numbers in lung cancer studies ASCO

Relaxed eligibility criteria would double patient numbers in lung cancer studies: ASCO

Broader clinical trial eligibility criteria would double patient numbers in lung cancer studies, according to a new report from ASCO, which has been leading efforts to expand access to oncology clinical trials.

More From BioPortfolio on "Relaxed eligibility criteria would double patient numbers in lung cancer studies: ASCO"